Efficacy of tacrolimus in Sjögren's syndrome-associated CNS disease with aquaporin-4 autoantibodies.
Fukuda
Taku
T
Shiraishi
Hirokazu
H
Nakamura
Tatsufumi
T
Tanaka
Keiko
K
Nakamura
Hideki
H
Tsujino
Akira
A
Nishiura
Yoshihiro
Y
Yoshimura
Toshiro
T
Motomura
Masakatsu
M
Eguchi
Katsumi
K
D051401:Aquaporin 4 / Q000276:immunology*; D001323:Autoantibodies / Q000378:metabolism*; D001921:Brain / Q000473:pathology; D002493:Central Nervous System Diseases / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D008875:Middle Aged; D012859:Sjogren's Syndrome / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D013116:Spinal Cord / Q000473:pathology; D016559:Tacrolimus / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome
C496030:AQP4 protein, human; D051401:Aquaporin 4; D001323:Autoantibodies; D007166:Immunosuppressive Agents; D016559:Tacrolimus